Início › Câncer de Mama › Flórida
Ensaios clínicos de Câncer de Mama em Flórida
146 estudos para Câncer de Mama estão buscando participantes em locais em Flórida.
Cidades em Flórida
- Tampa43 estudos
- Miami42 estudos
- Jacksonville40 estudos
- Orlando23 estudos
- Plantation14 estudos
- Sarasota12 estudos
- Gainesville12 estudos
- St. Petersburg11 estudos
- Cape Coral10 estudos
- Lakeland8 estudos
- Deltona8 estudos
- Davie7 estudos
- Clearwater6 estudos
- Hollywood6 estudos
- Miami Beach6 estudos
- West Palm Beach6 estudos
- Kendall5 estudos
- Deerfield Beach5 estudos
- Coral Springs4 estudos
- Boca Raton4 estudos
- Fort Lauderdale4 estudos
- Palm Bay3 estudos
- Doral3 estudos
- Tallahassee3 estudos
Texto oficial do estudo (Inglês)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
- Advent Health, Orlando
- Florida Cancer Specialists South, Port Charlotte
RecrutandoFase 1/2
Idades 12 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04585750Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
- Holy Cross Health, Fort Lauderdale
- Memorial Cancer Institute, Hollywood
- Jupiter Medical Center, Jupiter
RecrutandoFase 3
Idades de 18 a 100 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05827081Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
- Schulze Family Foundation Cancer Clinic - Bonita Health Center, Bonita Springs
- Morton Plant Hospital, Clearwater
- e mais 11
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus, Fort Myers
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06760819A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- AdventHealth Medical Group Oncology Research at Celebration, Kissimmee
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06172478A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
- Holy Cross Hospital, Fort Lauderdale
- The Oncology Institute, Lakeland
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT07102381Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Moffitt Cancer Center, Tampa
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06625775Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
- Mayo Clinic in Florida, Jacksonville
RecrutandoFase 2Voluntários saudáveis bem-vindos
Idades de 18 a 45 · Mulheres · Atualizado em 1 de out. de 2026 · NCT05557877A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
- Mayo Clinic Florida, Jacksonville
- Cancer Specialists of North Florida, Jacksonville
- Moffitt Cancer Center, Tampa
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06369285Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Helios CR Inc, Lakeland
- H. Lee Moffitt Cancer Center and Research Institute, Tampa
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT06324357The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Mayo Clinic in Florida, Jacksonville
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07285044Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
- University of Florida Proton Therapy Institute, Jacksonville
- Dwoskin Proton Therapy Center, Miami
- Miami Cancer Institute, Miami
RecrutandoFase 3
Idades 19 e acima · Mulheres · Atualizado em 29 de set. de 2026 · NCT05856773A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Research Site, Jacksonville
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT05877599A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
- Florida Cancer Specialists & Research Institute - Sarasota Cattlemen, Sarasota
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07578571Study of AVZO-021 in Patients With Advanced Solid Tumors
- Avenzo Therapeutics Recruiting Site, Sarasota
- Avenzo Therapeutics Recruiting Site, Tampa
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT05867251A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
- AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0024), Altamonte Springs
- Comprehensive Hematology Oncology ( Site 0060), St. Petersburg
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07060807Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
- Baptist MD Anderson Cancer Center, Jacksonville
Recrutando
Idades 30 e acima · Mulheres · Atualizado em 25 de set. de 2026 · NCT02945579A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0044), Altamonte Springs
- Florida Cancer Specialists - South ( Site 7004), Fort Myers
- Bioresearch Partner ( Site 0072), Hialeah
- e mais 2
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06966700A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
- AdventHealth Altamonte Springs ( Site 0021), Altamonte Springs
- Orlando Health Cancer Institute ( Site 0011), Orlando
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06312176The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
- Miami Cancer Institute, Miami
- Miami Cancer Institute, Plantation
RecrutandoFase 3
Idades 60 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06377852A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Research Site, Altamonte Springs
- Research Site, Miami
- Research Site, Plantation
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06103864Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer
- Morton Plant Hospital - Baycare Health System, Clearwater
- Moffitt Cancer Center, Tampa
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT05528133ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
- Mayo Clinic, Jacksonville
- Sylvester Comprehensive Cancer Center, Miami
- Moffitt Cancer Center, Tampa
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07007559A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer
- D&H National Research Centers INC (Investigational Site number USA-002), Margate
- United Medical Research (Investigational Site number USA-005), Port Orange
RecrutandoFase 1
Idades de 18 a 80 · Mulheres · Atualizado em 23 de set. de 2026 · NCT07401381Remotely-Delivered Cognitive Behavioral Stress Management for Breast Cancer (R-CBSM)
- University of Miami, Coral Gables
Recrutando
Idades 50 e acima · Mulheres · Atualizado em 23 de set. de 2026 · NCT07502352A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
- University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT06618287Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
- Clinical Trial Site, Tampa
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07085767Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
- Baptist MD Anderson, Jacksonville
- Mayo Clinic Florida, Jacksonville
- Jupiter Medical Cancer, Jupiter
- e mais 2
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07214532Precise Oncology Interventions in Nutrition and Training (OnPoint)
- University of Miami, Miami
RecrutandoVoluntários saudáveis bem-vindos
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT06534918A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- AdventHealth Altamonte Springs, Altamonte Springs
- Clermont Oncology Center, Clermont
- Florida Oncology & Hematology, Fort Myers
- e mais 4
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07174336A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Moffitt, Tampa
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07114601A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
- AdventHealth Altamonte Springs, Altamonte Springs
- Mayo Clinic in Florida, Jacksonville
RecrutandoFase 2
Idades 18 e acima · Mulheres · Atualizado em 22 de set. de 2026 · NCT07287098A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Moffitt, Tampa
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07213791A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer
- Florida Cancer Specialists, Sarasota
RecrutandoFase 1
Idades 18 e acima · Mulheres · Atualizado em 21 de set. de 2026 · NCT07524855Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
- TopLine MD Alliance, Miami
RecrutandoVoluntários saudáveis bem-vindos
Idades de 30 a 74 · Mulheres · Atualizado em 21 de set. de 2026 · NCT02620852Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
- Baptist Alliance Miami Cancer Institute, Miami
RecrutandoFase 2
Idades 45 e acima · Mulheres · Atualizado em 21 de set. de 2026 · NCT04084730Identifying Patterns in the Breath of Individuals With Breast Cancer
- Mayo Clinic Breast Clinic, Jacksonville
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 40 a 74 · Mulheres · Atualizado em 18 de set. de 2026 · NCT06512350ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
- Florida Cancer Specialists, Fort Myers
- Cancer Care Centers of Brevard, Inc, Palm Bay
- Sacred Heart Medical Oncology Group, Pensacola
- e mais 1
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT07173751A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- Florida Cancer Specialists - Lake Nona, Orlando
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT07109726A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
- Hematology - Oncology Associates of the Treasure Coast, Port Saint Lucie
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT06827236Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.